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Detecting
Clostridium 
botulinum
To the Editor: In the October
2005 issue of Emerging Infectious
Diseases, Song et al. described a
fiber-optic, microsphere-based, high-
density array composed of 18 species-
specific probe microsensors, used to
identify biological warfare agents,
including Clostridium botulinum (1).
Although the researchers used multi-
ple probes for C. botulinum, we doubt
that this approach is suitable for this
organism.
C. botulinum comprises a heteroge-
nous group of subspecies that produce
botulinum neurotoxin (BoNT); identi-
fication and characterization usually
rely on animal testing that focuses on
antigenetically distinct toxins (2).
Although strains of C. botulinum that
do not produce toxins are sometimes
isolated from wound infections not
related to botulism, some strains of C.
butyricum and C. baratii are also able
to produce BoNTs.
The mouse bioassay is currently
the accepted method for detecting
BoNT. In this assay, mice that receive
an intraperitoneal injection containing
a sample with more than a minimum
lethal dose show symptoms of botu-
linum intoxication and die. ELISAs,
which recognize protein antigenic
sites, are still less sensitive than the
mouse bioassay (3).
Because the mouse bioassay
requires euthanizing many animals,
and results are not available for sev-
eral hours, new diagnostic methods
are needed. For C. botulinum, an
organism widely dispersed in the
environment, DNA-based methods
may not provide the ultimate solu-
tion. Rapid methods to detect and dif-
ferentiate active BoNTs, such as the
rapid, mass spectrometry-based,
functional method, are promising
candidates to substitute for animal
testing in the near future (4).
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Echinococcus 
multilocularis in
Dogs, Japan
To the Editor: Alveolar echino-
coccosis in humans is endemic in
Japan; however, the causal agent,
Echinococcus multilocularis, has
been restricted to the northernmost
insular prefecture of Hokkaido, where
the Tsugaru Strait acts as a natural
physical barrier against migration to
the mainland. Two E. multilocularis
invasions into Hokkaido have
occurred (1). The first invasion to the
offshore island of Rebun in the mid-
1920s was successfully controlled;
however, the second invasion, sup-
posedly in the 1940s, led to the cur-
rent epidemic on the main island of
Hokkaido. Both invasions were
entirely or partly caused by humans
who removed foxes from disease-
endemic areas without taking the nec-
essary precautions.
The finding of 19 autochthonously
acquired cases of alveolar echinococ-
cosis in prefectures other than
Hokkaido (2) implies that the parasite
exists in other areas, although the
source of infection has yet to be iden-
tified. In many countries, studies of
the increased spread of the parasite
have traditionally focused on the con-
tribution of foxes (3); however, these
cases may also have been spread by
domestic dogs from disease-endemic
areas. Dogs are susceptible to infec-
tion with the parasite from rodents.
Although the prevalence of E. multi-
locularis among dogs in Hokkaido is
certainly lower than that in foxes
(4–6), dogs can traverse considerably
greater distances by various modes of
transport. The number of dogs that
travel from Hokkaido to other prefec-
tures has been estimated at >12,000
per year (7). Although dogs may
carry the parasite to remote areas, sur-
veys of population dynamics have not
been undertaken. We therefore stud-
ied the extent of E. multilocularis
infection in dogs being transported by
their owners from 4 ferry ports in
Hokkaido (Hakodate, Muroran,
Otaru, and Tomakomai) from Sep-
tember 2003 through October 2004. 
We tested 183 fecal samples from
41 resident (in Hokkaido) and 142
nonresident dogs. We screened for the
Echinococcus-specific coproantigen
by using a commercial enzyme-linked
immunosorbent assay kit (CHEKIT-
Echinotest, Bommeli Diagnostics,
Liebefeld-Bern, Switzerland) and fol-
lowing the manufacturer’s recom-
mendations. One dog from each group
had the Echinococcus coproantigen.
To confirm the specificity of the
results, these 2 dogs were treated with
1 oral dose of praziquantel, 5 mg/kg.
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Subsequent fecal samples were sub-
jected to coproantigen testing and
specific PCR amplification according
to the method of Dinkel et al. (8). The
coproantigen test showed a significant
reduction in the optical density value
for both dogs, which can be interpret-
ed as effective deworming for
Echinococcus. However, different
results were obtained for the PCR test,
in which assays of fecal samples from
the nonresident dog during the second
round of nested PCR produced a sin-
gle band of the expected size (Figure).
Direct sequencing showed that the
band was the same as bands obtained
for E. multilocularis isolates from
Hokkaido (GenBank accession no.
AB243207). Conversely, fecal sam-
ples from the resident dog did not
yield any positive PCR results.
The reason for the discrepancy is
unclear, but it may be a false reaction
in either test. Given that a reduced
optical density value was obtained
after administration of the taeniacidal
drug, the false-positive result of the
coproantigen test might have been
caused by another taeniid species.
Such cross-reaction has been reported
previously with this test (9). However,
no worm debris was found in the fecal
samples. Alternatively, sexual matura-
tion or low infection intensity of E.
multilocularis may produce false-neg-
ative results in PCR assays (8). Thus,
because the owner stated that the dog
was allowed to roam freely and fre-
quently preyed on rodents, this
coproantigen-positive but coproDNA-
negative dog was highly suspected of
being infected with E. multilocularis.
Infection among wild foxes can
spread to domestic dogs by way of
highly contaminated rodent hosts
(10). A nonresident dog became
infected with E. multilocularis despite
staying in Hokkaido for only 5 days
and being permitted to roam freely for
just a few hours. This finding suggests
a high infection pressure of E. multi-
locularis to domestic dogs within the
area. In addition, the increased popu-
larity of keeping dogs as companions,
greater frequency of dogs’ traveling
with their owners, and high preva-
lence in foxes from urban and rural
areas in Hokkaido (5,6) all contribute
to the possibility that E. multilocularis
could emerge in unsuspected loca-
tions. Thus, to prevent this parasite
from spreading, measures such as
those used by the Pet Travel Scheme
of the United Kingdom should be
applied to ensure that dogs from dis-
ease-endemic areas are pretreated
before entry to the main island of
Japan.
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Figure. Nested PCR amplification of coproDNA from 2 coproantigen-positive dogs. Lane
M, size marker (100-bp ladder); lane 1, nonresident dog (before treatment); lane 2, non-
resident dog (1 day after treatment); lane 3, resident dog (before treatment); lane 4, resi-
dent dog (1 day after treatment); lane 5, positive control; lane 6, negative control.
Arrowhead shows the expected band in a positive result.
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New World
Hantavirus in
Humans, French
Guiana
To the Editor: Hantaviruses are
etiologic agents for hemorrhagic fever
with renal syndrome in Europe and
Asia and for hantavirus pulmonary
syndrome (HPS) in the Americas.
These viruses belong to the family
Bunyaviridae, genus Hantavirus. The
natural reservoir of these viruses is
wild or domestic rodents. HPS was
first described in 1993 in the Four
Corners region of the United States
(1). It is a respiratory illness associat-
ed with the inhalation of aerosolized
rodent excreta (urine and feces) con-
taminated with hantavirus particles.
Sin Nombre virus (SNV) was the first
etiologic agent of this syndrome.
Since 1993, HPS has also been report-
ed and confirmed in 6 countries in
South America: Argentina, Bolivia,
Brazil, Chile, Paraguay, Uruguay
(2,3). Several distinct hantaviruses
have been associated with HPS,
including Juquituba virus in Brazil
(4), Andes virus in Southern
Argentina (5), and Laguna Negra
virus in Paraguay (6).
French Guiana, an overseas French
Administrative Unit in the Amazonian
forest complex, is located on the
northeastern coast of the South
America between Brazil and
Suriname. Ninety percent of its sur-
face is tropical rain forest; the remain-
ing 10% is a coastal plain, where 90%
of the 200,000 inhabitants live.
Cayenne and 2 adjacent towns,
Remire and Matoury, constitute the
main urban centers, with 80,000
inhabitants, ≈40% of the population.
People live mainly in individual hous-
es and small buildings. Many houses
are built near forests, except those in
the center of Cayenne. The outskirts
of Remire and Matoury are surround-
ed by secondary rain forest, and those
of Cayenne by wooded hills, where
wild mammals such as rodents live in
large numbers.
The prevalence of antibodies to
New World hantavirus is unknown in
French Guiana. Several cases of atyp-
ical pneumonia not linked to other eti-
ologic agents (Coxiella burnetii,
Histoplasma boydii), combined with
identification of hantavirus rodent
reservoirs in neighboring countries,
prompted us to determine the sero-
prevalence of hantavirus in this area
(7,8).
To estimate the prevalence of anti-
bodies to New World hantavirus, we
conducted a retrospective serologic
survey of patients with symptoms
compatible with HPS. Patients were
from all areas of French Guiana: 64%
from the urban centers, 7% from rural
regions, and 30% from unspecified
regions. From April 2002 through
April 2004, a total of 420 serum sam-
ples were collected from patients with
acute-phase febrile illness, unex-
plained acute respiratory syndrome,
or bilateral interstitial pulmonary
infiltrates. Diagnosis of Q fever was
excluded by negative serologic results
for immunoglobulin M (IgM), IgG, or
both to C. burnetii (bioMérieux,
Marcy-l’Etoile, France).
To detect patients with IgG anti-
bodies to SNV, the ELISA described
by Feldmann et al. was used (9).
Briefly, an SNV-positive serum pro-
vided by the Centers for Disease
Control and Prevention (CDC,
Atlanta, GA, USA) was used as a pos-
itive control. Negative controls were
obtained by random sampling of all
previously negative samples. A sam-
ple was considered positive if the net
absorbance values (after subtraction
of absorbance values with and with-
out antigen) were >0.2 for dilutions of
1:100 and 1:400 and the sum of 4 net
absorbance values was >0.95.
Seropositive samples were confirmed
at CDC.
Antibodies reactive with SNV
antigen indicate infection with a New
World hantaviruses. However,
because SNV is broadly cross-reac-
tive with most New World hantavirus,
the specific hantavirus cannot be
identified.
The seroprevalence of IgG anti-
body to hantavirus was 1.42% (6/420)
in the selected population. Three other
samples showed borderline positivity.
Antibody prevalence was not signifi-
cantly different among the 7 age
classes used (0–9, 10–19, 20–29,
30–39, 40–49, 50–59, and >60 years
of age, p = 0.36, degrees of freedom =
6, by χ2 test) or by sex (p = 0.22, by
Fisher exact test).
